Alto Neuroscience ANRO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$74.31M-17.6% | -$63.24M-2.9% | -$62.26M-8.4% | -$64.86M-30.2% | -$63.18M-48.9% | ||
| $641K0.0% | $628K+10.8% | $641K+25.9% | $641K+56.7% | $641K+56.7% | ||
| $8.96M+20.8% | $8.11M+6.3% | $7.73M+15.8% | $7.54M+44.6% | $7.42M+61.8% | ||
| -$62.3M-17.6% | -$51.77M-9.2% | -$53.27M-16.0% | -$55.08M-31.3% | -$53M-43.6% | ||
| —— | —— | —— | —— | $1.88M+179% | ||
| —— | —— | —— | —— | -$1.88M-179% | ||
| —— | —— | —— | —— | $10.21M— | ||
| $165.89M+1,481% | $60.08M-55.8% | $9.94M-94.4% | $11.11M-93.8% | $10.49M-94.1% | ||
| $103.01M— | $8.26M— | —— | —— | —— | ||
| -$62.86M-14.6% | -$51.79M-4.6% | -$53.8M-12.4% | -$56.62M-31.9% | -$54.87M-46.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Alto Neuroscience generate?
- Alto Neuroscience (ANRO) generated -$62.3M in operating cash flow over the trailing twelve months.
- What is Alto Neuroscience's free cash flow?
- After $2.1M of capital expenditures, Alto Neuroscience's free cash flow was -$62.9M over the trailing twelve months, down 14.6% year over year.
- Where does Alto Neuroscience's cash flow data come from?
- Every line is extracted from Alto Neuroscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.